Literature DB >> 10776430

Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience.

M F Gerhards1, T M van Gulik, L T de Wit, H Obertop, D J Gouma.   

Abstract

BACKGROUND: Hilar resection, especially in combination with liver resection, results in substantial morbidity and mortality, which clearly influences the overall outcome. In the present study, patients who underwent resection of a proximal bile duct tumor were analyzed with the aim of identifying risk factors for morbidity and mortality.
METHODS: Between 1983 and 1998, 112 consecutive patients underwent a local resection, which in 32 patients was combined with a hemihepatectomy (11 extended resections). Eighty-four percent of the patients underwent preoperative (endoscopic) drainage. For evaluation of different treatment strategies during the study, the period was divided in three 5-year intervals.
RESULTS: Postoperative complications occurred in 65% of the patients. The overall hospital mortality was 15% for local resections and 25% for hemi-hepatectomies. There was a significantly lower morbidity and no mortality after hilar resection during the last 5 years. A higher Bismuth classification showed significant correlation with postoperative morbidity. Extended liver resections and vascular resections and a preoperative albumin level below 35 g/L were found to be significant predictors of increased mortality in univariate analysis.
CONCLUSIONS: The overall morbidity and mortality rate in this series is higher than most recently published series. More (extended) liver resections resulted in an increased rate of microscopic tumor-free resections, at the cost of higher hospital morbidity and mortality. Improved preoperative work-ups will result in a selection of patients who might benefit from these extensive resections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10776430     DOI: 10.1067/msy.2000.104250

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  66 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

2.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

3.  Improving outcomes in cholangiocarcinomas.

Authors:  Charles Imber; Justin Stebbing; Arjun Shankar
Journal:  Gastrointest Cancer Res       Date:  2011-09

Review 4.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

5.  Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Authors:  Noriaki Sagawa; Satoshi Kondo; Toshiaki Morikawa; Shunichi Okushiba; Hiroyuki Katoh
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

6.  One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.

Authors:  Tsuyoshi Sano; Kazuaki Shimada; Yoshihiro Sakamoto; Junji Yamamoto; Susumu Yamasaki; Tomoo Kosuge
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

7.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

8.  Outcome of surgical treatment of hilar cholangiocarcinoma.

Authors:  Kazuhiro Otani; Kazuo Chijiiwa; Masahiro Kai; Jiro Ohuchida; Motoaki Nagano; Kazuyo Tsuchiya; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

9.  Management of hepatobiliary and pancreatic disorders at the Academic Medical Center Amsterdam, Netherlands.

Authors:  D J Gouma; H Obertop
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

10.  Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.

Authors:  Yasuji Seyama; Keiichi Kubota; Keiji Sano; Tamaki Noie; Tadatoshi Takayama; Tomoo Kosuge; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.